Successful approval of Proposition 122 in Colorado made it the second state in the US to decriminalize hallucinogenic mushrooms like psilocybin. Clinics…
McAlinden Research PartnersNovember 17, 2022
President Trump's bout of COVID-19 launched countless headlines regarding the some of the leading experimental treatments he'd be receiving - therapeutics…
McAlinden Research PartnersOctober 13, 2020
New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…
McAlinden Research PartnersNovember 13, 2019
The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…
McAlinden Research PartnersOctober 21, 2019
